相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28
Ines Mueller et al.
MOLECULAR CELL (2020)
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
Yuan Fang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients
Thorsten Heilmann et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
Ufuk Mert et al.
CANCERS (2019)
Crosstalk between p53 modifiers at PML bodies
Sonja Matt et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
Florent Dufour et al.
ONCOTARGET (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
TRAIL-death receptor endocytosis and apoptosis are selectively regulated by dynamin-1 activation
Carlos R. Reis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
Silvia von Karstedt et al.
CANCER CELL (2015)
TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
Hendrik Fritsche et al.
ONCOTARGET (2015)
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
Baolin Zhang et al.
Oncotarget (2015)
Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
Verena Haselmann et al.
GASTROENTEROLOGY (2014)
Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis
Min Lu et al.
SCIENCE (2014)
Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
U. Bertsch et al.
CELL DEATH & DISEASE (2014)
Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
K. Azijli et al.
CELL DEATH AND DIFFERENTIATION (2013)
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5
Xu Di et al.
ONCOTARGET (2013)
Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells
Yuko Kojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
Frederik J. H. Hoogwater et al.
GASTROENTEROLOGY (2010)
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Michael H. Tatham et al.
NATURE CELL BIOLOGY (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53
K. Henning et al.
CELL DEATH AND DIFFERENTIATION (2008)
Role of caspases in CD95L-and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells
Daniela Siegmund et al.
CELLULAR SIGNALLING (2007)
SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination
Moon Hee Lee et al.
NATURE CELL BIOLOGY (2006)
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
A. Trauzold et al.
ONCOGENE (2006)
Pl-3K/Akt and NF-κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatment
G Zauli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
PML regulates p53 stability by sequestering Mdm2 to the nucleolus
R Bernardi et al.
NATURE CELL BIOLOGY (2004)
Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells
A Trauzold et al.
BRITISH JOURNAL OF CANCER (2003)
The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation
I Louria-Hayon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells
A Trauzold et al.
ONCOGENE (2001)
The function of PML in p53-dependent apoptosis
A Guo et al.
NATURE CELL BIOLOGY (2000)
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
M Pearson et al.
NATURE (2000)
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
AM Chinnaiyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
R Takimoto et al.
ONCOGENE (2000)
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
SB Gibson et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
